India Globalization Capital (IGC) Stock Skyrockets By 101% After Getting Approved Of Its Treatment Of Alzheimer’s: Not Late To Buy To Buy

IGC has some great results for those who like penny stock that rises at enormous speed. The stock rises 75% in pre-market. On July 19 the stock was low at $1.36 then it started to skyrocket at high speed. The stock reached the price of $1.45 by July 20. As of the last trading session, the stock has soared by 4.23%. The company’s market capitalization is worth $71.524 million.

On July 20, 2021, the US Patent and Trademark Office issued a patent for a drug that could be used to treat Alzheimer’s disease. The original patent application was filed in 2016 by the University of Florida. In 2017, IGC entered into a license agreement with USF to exclusively license the patent. The granted patent pertains to IGC’s proprietary formulation of THC for the treatment of Alzheimer’s disease.

India Globalization Capital, Inc. is a vertically integrated infrastructure company that purchases and resells physical commodities. It also develops and sells various products and services related to cannabinoids. These include hemp-based CBD products, which are being used for the treatment of various conditions, such as anxiety and depression.

Helen Larsen

After a long week of holidays in 2020, Helen realized she can do better in reporting Finance and Business news for Own Snap. Right now she is our weekend reporter and author. Sometimes she is busy with her projects that are related to her Master's Degree in Finance.

Want Hot Stocks?    Yes. I Love Them No thanks